(Q90293831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

title

Production of β-Lactamase Inhibitors by Streptomyces Species (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author

Valéria C Santos-Ebinuma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Daniela de Araújo Viana Marques

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Suellen Emilliany Feitosa Machado

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Carolina de Albuquerque Lima Duarte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Attilio Converti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Ana Lúcia Figueiredo Porto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

17 July 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

Antibiotics (Basel, Switzerland)

12 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 April 2020

copyright license

start time

17 July 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Naturally-occurring beta-lactamase inhibitors with antibacterial activity

1 reference

12 December 2020

Utilization of ornithine and arginine as specific precursors of clavulanic acid

1 reference

12 December 2020

An enzyme from bacteria able to destroy penicillin. 1940.

1 reference

12 December 2020

Beta-lactamase inhibitors from laboratory to clinic

1 reference

12 December 2020

Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections

1 reference

12 December 2020

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

12 December 2020

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus

1 reference

12 December 2020

Simultaneous production and decomposition of clavulanic acid during Streptomyces clavuligerus cultivations

1 reference

12 December 2020

New type of hexameric ornithine carbamoyltransferase with arginase activity in the cephamycin producers Streptomyces clavuligerus and Nocardia lactamdurans.

1 reference

12 December 2020

Chemistry and biosynthesis of clavulanic acid and other clavams

1 reference

12 December 2020

Manipulation of the physiology of clavulanic acid production in Streptomyces clavuligerus

1 reference

12 December 2020

Bacterial production of carbapenems and clavams: evolution of beta-lactam antibiotic pathways.

1 reference

12 December 2020

Coordinate production of cephamycin c and clavulanic acid by Streptomyces clavuligerus

1 reference

12 December 2020

Changing patterns of infectious disease

1 reference

12 December 2020

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

1 reference

12 December 2020

How many antibiotics are produced by the genus Streptomyces?

1 reference

12 December 2020

Kinetic studies of clavulanic acid recovery by ion exchange chromatography

1 reference

12 December 2020

New reactions in clavulanic acid biosynthesis

1 reference

12 December 2020

Improved production of teicoplanin using adsorbent resin in fermentations

1 reference

12 December 2020

Why is big Pharma getting out of antibacterial drug discovery?

1 reference

12 December 2020

Antibacterial drug discovery in the 21st century

1 reference

12 December 2020

Antibacterial drug discovery: is small pharma the solution?

1 reference

12 December 2020

Regulation and biosynthesis of carbapenem antibiotics in bacteria.

1 reference

12 December 2020

Optimization and scale up of industrial fermentation processes

1 reference

12 December 2020

Influence of feeding conditions on clavulanic acid production in fed-batch cultivation with medium containing glycerol

1 reference

12 December 2020

Rational strain improvement for enhanced clavulanic acid production by genetic engineering of the glycolytic pathway in Streptomyces clavuligerus

1 reference

12 December 2020

Strain Specificity and Production of Antibiotic Substances: V. Strain Resistance of Bacteria to Antibiotic Substances, Especially to Streptomycin

1 reference

12 December 2020

Optimization of nutritional requirements and feeding strategies for clavulanic acid production by Streptomyces clavuligerus.

1 reference

12 December 2020

Antibacterial discovery and development--the failure of success?

1 reference

12 December 2020

5S clavam biosynthetic genes are located in both the clavam and paralog gene clusters in Streptomyces clavuligerus.

1 reference

12 December 2020

A statistical approach using L(25) orthogonal array method to study fermentative production of clavulanic acid by Streptomyces clavuligerus MTCC 1142.

1 reference

12 December 2020

Chloromycetin, a New Antibiotic From a Soil Actinomycete

1 reference

12 December 2020

Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.

1 reference

12 December 2020

Sulbactam-containing beta-lactamase inhibitor combinations

1 reference

12 December 2020

Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350

1 reference

12 December 2020

Clavulanic acid: a review.

1 reference

12 December 2020

Antibiotic overproduction in Streptomyces coelicolor A3 2 mediated by phosphofructokinase deletion

1 reference

12 December 2020

Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering

1 reference

12 December 2020

A novel finding that Streptomyces clavuligerus can produce the antibiotic clavulanic acid using olive oil as a sole carbon source.

1 reference

12 December 2020

An approach to strain improvement and enhanced production of clavulanic acid in Streptomyces clavuligerus

1 reference

12 December 2020

Screening of variables influencing the clavulanic acid production by Streptomyces DAUFPE 3060 strain.

1 reference

12 December 2020

Antibiotics for emerging pathogens

1 reference

12 December 2020

Updated functional classification of beta-lactamases

1 reference

12 December 2020

Streptomyces scabies87-22 Contains a Coronafacic Acid-Like Biosynthetic Cluster That Contributes to Plant–Microbe Interactions

1 reference

12 December 2020

Three decades of beta-lactamase inhibitors

1 reference

12 December 2020

Call of the wild: antibiotic resistance genes in natural environments

1 reference

12 December 2020

Clavulanic acid biosynthesis and genetic manipulation for its overproduction

1 reference

12 December 2020

Penicillin resistant staphylococci.

1 reference

12 December 2020

Production of extracellular penicillin-inactivating substances associated with penicillin resistance in Staphylococcus aureus.

1 reference

12 December 2020

Penicillin resistance of Staphylococcus aureus and its clinical implications

1 reference

12 December 2020

Studies on the action of penicillin; development of penicilli resistance by gonococcus

1 reference

12 December 2020

Studies on induced resistance to penicillin in a pneumococcus type I.

1 reference

12 December 2020

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

1 reference

12 December 2020

Extractive fermentation of clavulanic acid by Streptomyces DAUFPE 3060 using aqueous two-phase system

1 reference

12 December 2020

Recombinant organisms for production of industrial products

1 reference

12 December 2020

Activity of carbapenems combined with clavulanate against murine tuberculosis

1 reference

12 December 2020

Separation of clavulanic acid from fermented broth of amino acids by an aqueous two-phase system and ion-exchange adsorption

1 reference

12 December 2020

Evaluation of different detection methods of biofilm formation in the clinical isolates.

1 reference

12 December 2020

A comparison of the clavam biosynthetic gene clusters in Streptomyces antibioticus Tü1718 and Streptomyces clavuligerus

1 reference

12 December 2020

Exploiting adaptive laboratory evolution of Streptomyces clavuligerus for antibiotic discovery and overproduction

1 reference

12 December 2020

Antibiotics produced by Streptomyces

1 reference

12 December 2020

The enzymes of β-lactam biosynthesis

1 reference

12 December 2020

Molecular biology of drug resistance in Mycobacterium tuberculosis

1 reference

12 December 2020

Recent advances in the biosynthesis of penicillins, cephalosporins and clavams and its regulation

1 reference

12 December 2020

Metallo-β-lactamase: inhibitors and reporter substrates

1 reference

12 December 2020

Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria

1 reference

12 December 2020

Butanol production from wood pulping hydrolysate in an integrated fermentation-gas stripping process

1 reference

12 December 2020

Optimization of clavulanic acid production by Streptomyces daufpe 3060 by response surface methodology

1 reference

12 December 2020

Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012).

1 reference

12 December 2020

In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China

1 reference

12 December 2020

Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.

1 reference

12 December 2020

New β-lactamase inhibitors: a therapeutic renaissance in an MDR world

1 reference

12 December 2020

Production of clavulanic acid and cephamycin C by Streptomyces clavuligerus in palm-oil medium

1 reference

12 December 2020

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

1 reference

12 December 2020

Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).

1 reference

12 December 2020

Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).

1 reference

12 December 2020

Clavulanic acid production by the MMS 150 mutant obtained from wild type Streptomyces clavuligerus ATCC 27064.

1 reference

12 December 2020

Antimicrobial activity of cefepime-tazobactam combination tested against clinical isolates of Enterobacteriaceae

1 reference

12 December 2020

Microbiological effects of sublethal levels of antibiotics.

1 reference

12 December 2020

Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)

1 reference

12 December 2020

Heterologous expression of Streptomyces clavuligerus ATCC 27064 cephamycin C gene cluster.

1 reference

12 December 2020

Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011).

1 reference

12 December 2020

In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases

1 reference

12 December 2020

Isolation, screening and partial purification of antimicrobial antibiotics from soil Streptomyces sp. SCA 7.

1 reference

12 December 2020

Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48

1 reference

12 December 2020

Screening of wild type Streptomyces isolates able to overproduce clavulanic acid.

1 reference

12 December 2020

In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays

1 reference

12 December 2020

Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes

1 reference

12 December 2020

In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.

1 reference

12 December 2020

In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases

1 reference

12 December 2020

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

1 reference

12 December 2020

In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae

1 reference

12 December 2020

In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates

1 reference

12 December 2020

Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).

1 reference

12 December 2020

Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.

1 reference

12 December 2020

Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains

1 reference

12 December 2020

Clinical and Economic Impact of Empirical Extended-Infusion Piperacillin-Tazobactam in a Community Medical Center

1 reference

12 December 2020

Implementation of Hospital's Antibiotic Policy Decreases Antimicrobial Use in the General Pediatric Ward

1 reference

12 December 2020

Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia

1 reference

12 December 2020

In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.

1 reference

12 December 2020

Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City

1 reference

12 December 2020

Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals

1 reference

12 December 2020

OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'

1 reference

12 December 2020

A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens

1 reference

12 December 2020

Access to effective antimicrobials: a worldwide challenge

1 reference

12 December 2020

Antibacterial drug discovery in the resistance era.

1 reference

12 December 2020

Molecular Basis for Resistance Against Phosphonate Antibiotics and Herbicides

1 reference

12 December 2020

Inversion of the stereochemical configuration (3S, 5S)-clavaminic acid into (3R, 5R)-clavulanic acid: A computationally-assisted approach based on experimental evidence.

1 reference

12 December 2020

Fermentation Conditions that Affect Clavulanic Acid Production in Streptomyces clavuligerus: A Systematic Review

1 reference

12 December 2020

Self-resistance in Streptomyces, with Special Reference to β-Lactam Antibiotics

1 reference

12 December 2020

New β-Lactamase Inhibitors in the Clinic

1 reference

12 December 2020

β-Lactams and β-Lactamase Inhibitors: An Overview

1 reference

12 December 2020

β-Lactams against Tuberculosis--New Trick for an Old Dog?

1 reference

12 December 2020

Effect of aeration and agitation on extractive fermentation of clavulanic acid by using aqueous two-phase system.

1 reference

12 December 2020

Inhibiting Mycobacterium tuberculosis within and without

1 reference

12 December 2020

Repurposing clinically approved cephalosporins for tuberculosis therapy

1 reference

12 December 2020

Novel non-β-lactam inhibitor of β-lactamase TEM-171 based on acylated phenoxyaniline.

1 reference

12 December 2020

Antibiotic resistance in the wild: an eco-evolutionary perspective

1 reference

12 December 2020

Recent advances in understanding Streptomyces

1 reference

12 December 2020

Isolation, Screening, and Identification of Novel Isolates of Actinomycetes from India for Antimicrobial Applications.

1 reference

12 December 2020

Characterization of β-lactamase activity using isothermal titration calorimetry.

1 reference

12 December 2020

The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.

1 reference

12 December 2020

In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents

1 reference

12 December 2020

Kinase inhibitors in clinical practice: An expanding world.

1 reference

12 December 2020

Antibiotic efficacy in the complex infection environment.

1 reference

12 December 2020

Proteome-wide alterations in an industrial clavulanic acid producing strain of Streptomyces clavuligerus

1 reference

12 December 2020

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.

1 reference

12 December 2020

An update on β-lactamase inhibitor discovery and development.

1 reference

12 December 2020

Screening of medium constituents for clavulanic acid production by Streptomyces clavuligerus.

1 reference

12 December 2020

Nephrotoxicity of piperacillin-tazobactam combined with vancomycin: Should it be a concern?

1 reference

12 December 2020

Antibiotic Resistance: Current Perspectives

1 reference

12 December 2020

10.3390/ANTIBIOTICS7030061

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30018235%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference